India's Biocon received approval for a generic version of Roche's breast-cancer drug Herceptin in India. Roche had decided not to seek patent approval for the drug there.
from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304281004579221971613720720.html?mod=pls_whats_news_us_business_f
via IFTTT
from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304281004579221971613720720.html?mod=pls_whats_news_us_business_f
via IFTTT
No comments:
Post a Comment